Jim Keon is President of the Canadian Generic Pharmaceutical Association (CGPA), and President of Biosimilars Canada organizations representing Canada’s generic and biosimilar pharmaceutical sectors.
Jim graduated with an M.A. in Economics from Queen’s University and has more than 25 years experience in the pharmaceutical sector.
Jim has served as President of the CGPA since 1998 and was named the founding President of Biosimilars Canada in January 2015. Prior to joining CGPA in 1994 he held senior positions in the federal government and was directly involved in international trade negotiations for NAFTA and the WTO, as well as Canada’s inter-provincial trade negotiations.
Jim is a past Chair and a current member of the Management Committee of the International Generic and Biosimilars Medicines Association (IGBA). The IGBA is committed to promoting the interests of generic and biosimilars medicines around the world.